218 related articles for article (PubMed ID: 10775108)
61. C-terminal modification of the insulin B:11-23 peptide creates superagonists in mouse and human type 1 diabetes.
Wang Y; Sosinowski T; Novikov A; Crawford F; Neau DB; Yang J; Kwok WW; Marrack P; Kappler JW; Dai S
Proc Natl Acad Sci U S A; 2018 Jan; 115(1):162-167. PubMed ID: 29255035
[TBL] [Abstract][Full Text] [Related]
62. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
[TBL] [Abstract][Full Text] [Related]
63. Structural and functional consequences of altering a peptide MHC anchor residue.
Kersh GJ; Miley MJ; Nelson CA; Grakoui A; Horvath S; Donermeyer DL; Kappler J; Allen PM; Fremont DH
J Immunol; 2001 Mar; 166(5):3345-54. PubMed ID: 11207290
[TBL] [Abstract][Full Text] [Related]
64. Peptide analysis, stability studies, and structural modeling explain contradictory peptide motifs and unique properties of the NOD mouse MHC class II molecule H2-A(g7).
Münz C; Hofmann M; Yoshida K; Moustakas AK; Kikutani H; Stevanoviç S; Papadopoulos GK; Rammensee HG
Eur J Immunol; 2002 Aug; 32(8):2105-16. PubMed ID: 12209622
[TBL] [Abstract][Full Text] [Related]
65. The role of MHC class II molecules in the pathogenesis and prevention of Type I diabetes.
McDevitt H
Adv Exp Med Biol; 2001; 490():59-66. PubMed ID: 11505975
[No Abstract] [Full Text] [Related]
66. Increased entry into the IFN-gamma effector pathway by CD4+ T cells selected by I-Ag7 on a nonobese diabetic versus C57BL/6 genetic background.
Koarada S; Wu Y; Ridgway WM
J Immunol; 2001 Aug; 167(3):1693-702. PubMed ID: 11466393
[TBL] [Abstract][Full Text] [Related]
67. Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition.
Zhang W; Young AC; Imarai M; Nathenson SG; Sacchettini JC
Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8403-7. PubMed ID: 1325657
[TBL] [Abstract][Full Text] [Related]
68. Insights into the chemistry and biology of the I-Ag7 class II molecule.
Carrasco-Marin E; Kanagawa O; Unanue ER
Res Immunol; 1997 Jun; 148(5):291-301. PubMed ID: 9352592
[No Abstract] [Full Text] [Related]
69. Do MHC antigens generate pathogenetic peptides?
Baum H; Cunningham P
Immunol Today; 1994 Aug; 15(8):388-9. PubMed ID: 7916954
[No Abstract] [Full Text] [Related]
70. T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.
Morkowski S; Goldrath AW; Eastman S; Ramachandra L; Freed DC; Whiteley P; Rudensky AYu
J Exp Med; 1995 Nov; 182(5):1403-13. PubMed ID: 7595211
[TBL] [Abstract][Full Text] [Related]
71. Modelling of the MHC II allele I-A(g7) of NOD mouse: pH-dependent changes in specificity at pockets 9 and 6 explain several of the unique properties of this molecule.
Moustakas AK; Routsias J; Papadopoulos GK
Diabetologia; 2000 May; 43(5):609-24. PubMed ID: 10855536
[TBL] [Abstract][Full Text] [Related]
72. Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove.
Fremont DH; Stura EA; Matsumura M; Peterson PA; Wilson IA
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2479-83. PubMed ID: 7708669
[TBL] [Abstract][Full Text] [Related]
73. Bound peptide-dependent thermal stability of major histocompatibility complex class II molecule I-Ek.
Saito K; Oda M; Sarai A; Azuma T; Kozono H
Biochemistry; 2004 Aug; 43(31):10186-91. PubMed ID: 15287746
[TBL] [Abstract][Full Text] [Related]
74. Selection of aberrant class II restricted CD8+ T cells in NOD mice expressing a glutamic acid decarboxylase (GAD)65-specific T cell receptor transgene.
Ranheim EA; Tarbell KV; Krogsgaard M; Mallet-Designe V; Teyton L; McDevitt HO; Weissman IL
Autoimmunity; 2004 Dec; 37(8):555-67. PubMed ID: 15763918
[TBL] [Abstract][Full Text] [Related]
75. Aspartic acid homozygosity at codon 57 of HLA-DQ beta is associated with susceptibility to pulmonary tuberculosis in Cambodia.
Delgado JC; Baena A; Thim S; Goldfeld AE
J Immunol; 2006 Jan; 176(2):1090-7. PubMed ID: 16393997
[TBL] [Abstract][Full Text] [Related]
76. Molecular basis for recognition of an arthritic peptide and a foreign epitope on distinct MHC molecules by a single TCR.
Basu D; Horvath S; Matsumoto I; Fremont DH; Allen PM
J Immunol; 2000 Jun; 164(11):5788-96. PubMed ID: 10820257
[TBL] [Abstract][Full Text] [Related]
77. Reversal of type 1 diabetes by a new MHC II-peptide chimera: "Single-epitope-mediated suppression" to stabilize a polyclonal autoimmune T-cell process.
Lin M; Stoica-Nazarov C; Surls J; Kehl M; Bona C; Olsen C; Brumeanu TD; Casares S
Eur J Immunol; 2010 Aug; 40(8):2277-88. PubMed ID: 20540111
[TBL] [Abstract][Full Text] [Related]
78. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes.
Chen C; Lee WH; Yun P; Snow P; Liu CP
J Immunol; 2003 Jul; 171(2):733-44. PubMed ID: 12847240
[TBL] [Abstract][Full Text] [Related]
79. Autoreactivity of T cells from nonobese diabetic mice: an I-Ag7-dependent reaction.
Kanagawa O; Martin SM; Vaupel BA; Carrasco-Marin E; Unanue ER
Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1721-4. PubMed ID: 9465083
[TBL] [Abstract][Full Text] [Related]
80. IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule.
Trembleau S; Gregori S; Penna G; Gorny I; Adorini L
J Immunol; 2001 Oct; 167(7):4104-14. PubMed ID: 11564833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
